Fluvastatin XL 80 mg tablet has been marketed in Indonesia since Desember 2002. This post-marketing surveillance (PMS) was conducted between May 2004 and April 2005 involving 98 general physicians to observe the sofety and tolerability of fluvastatin XL 80 mg once daily at bedtime for 8 weeks in the treatment of outpatiens with hypercholesterolemia. The afficacy of the drug inlowering LDL chole…
Atherosclerosis and coronary heart disease are predicated to be prominent health problem in the next few years in Indonesia. High blood lipid level is considered to be among the risk factors. It can be controlled by medication and dietary measures. Tempe, a highly nutricious food, is known to contain many substances that could influence blood lipid level. This study was conducted to investigate…